JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (4): 50-55.doi: 10.6040/j.issn.1673-3770.0.2016.292

Previous Articles     Next Articles

Efficacy and safety of subcutaneous immunotherapy with house dust mite extract for allergic rhinitis.

TU Yanyi1,2, SHI Li1,2, ZHAO Li1,2, JIN Peng1,2, ZI Xiaoxue1,2, LI Ang1,2, JIN Yixuan1,2, ZHI Lili   

  1. 1. School of Medicine, Shandong University, Jinan 250012, Shandong, China;2. Department of Otolaryngology, The Second Hospital of Shandong University, Jinan 250033, Shandong, China;3. Department of Otolaryngology, Central Hospital of Zibo, Zibo 255031, Shandong, China
  • Received:2016-06-27 Online:2016-08-16 Published:2016-08-16

PDF (PC)

988

Abstract: Objective Investigate the efficacy and safety of 2-year subcutaneous immunotherapy(SCIT)with HDM extract for allergic rhinitis with/without asthma. Methods A total of 58 patients with HDM-induced AR(35 sensitized to HDM only and 23 sensitized to HDM and other allergens simultaneously)with/without asthma were included. Symptom scores, visual analogue scale and quality of life were assessed before and after 6, 12 and 24 months of SCIT. Local and systemic adverse events were recorded for safety. Results Symptom scores decreased significantly(P<0.05)after 6 months of immunotherapy for both AR and asthma, and continued to decline until the end of the treatment. There was no statistical difference(P>0.05)between monosensitized patients and polysensitized patients in symptom scores after 2-year SCIT. Marked improvements(P<0.05)in quality of life were also observed after 6, 12 and 24 months of SCIT. Most side-effects were local reactions, no serious adverse event was reported during the treatment. Conclusion For AR patients, especially accompanied with asthma, SCIT is an effective and safe treatment.

Key words: Subcutaneous immunotherapy, House dust mite, Efficacy, Asthma, Allergic rhinitis

CLC Number: 

  • R765.21
[1] 韩德民,张罗,黄丹,等.我国11个城市变应性鼻炎自报患病率调查[J].中华耳鼻咽喉头颈外科杂志,2007,42(5):378-384. HAN Demin, ZHANG Luo, HUANG Dan, et al. Self-reported prevalence of allergic rhinitis in eleven cities in China[J]. Chin J Otorhinolaryngol Head Neck Surgery, 2007, 42(5):378-384.
[2] Law M, Morris JK, Wald N, et al: Changes in atopy over a quarter of a century, based on cross-sectional data at three time periods[J]. BMJ, 2005, 330(7501):1187-1188.
[3] Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma(ARIA)2008 update[J]. Allergy, 2008, 63(Suppl 86):8-160.
[4] Pichler C E, Marquardsen A, Sparholt S, et al. Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity[J]. Allergy, 1997, 52(3):274-283.
[5] Noon L. Prophylactic inoculation against hay fever[J]. Int Arch Allergy Appl Immunol, 1953, 4:285-288.
[6] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎诊断和治疗指南(2015年,天津)[J]. 中华耳鼻咽喉头颈外科杂志,2016,51(1):6-24.
[7] Canonica G W. A survey of the burden of allergic rhinitis in Europe[J]. Allergy, 2007, 62(Suppl):17-25.
[8] 中华耳鼻咽喉头颈外科杂志编委会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎诊断和治疗指南(2009年,武夷山)[J]. 中华耳鼻咽喉头颈外科杂志,2009,44(12):977-978.
[9] Juniper E F. Measuring health-related quality of life in rhinitis[J]. J Allergy Clin Immunol, 1997, 99(2):742-749.
[10] Juniper E F, Guyatt G H, Ferrie P J, et al. Measuring quality of life in asthma[J]. Am Rev Resp Dis, 1993, 147(4):832-838.
[11] Cox L, Wallace D. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual[J]. Immunol Allergy Clin North Am, 2011, 31(3):561-599.
[12] 中华耳鼻咽喉头颈外科杂志编委会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎特异性免疫治疗专家共识[J]. 中华耳鼻咽喉头颈外科杂志,2011,46(12):976-980.
[13] Sporik R, Holgate S T, Platts-Mills T A, et al. Exposure to house-dust mite allergen(Der pI)and the development of asthma in childhood. A prospective study[J]. N Engl J Med, 1990, 323(8):502-507.
[14] 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉科学分会.变应性鼻炎的诊治原则和推荐方案(2004年,兰州)[J].中华耳鼻咽喉头颈外科杂志,2005,40(3):166-167.
[15] Bousquet J, Braquemond P, Feinberg J, et al. Specific IgE response before and after rush immunotherapy with a standardized allergen or allergoid in grass pollen allergy[J]. Ann Allergy, 1986, 56(6):456-459.
[16] 孙劲旅, 陈军, 张宏誉. 尘螨过敏原的交叉反应性[J]. 昆虫学报, 2006, 49(4): 695-699. SUN Jinlu, CHEN Jun, ZHANG Hongyu. Allergenic cross-reactivity between house dust mites and other mites[J]. Acta Entomologica Sinica, 2006, 49(4):695-699.
[17] Chen J, Li B, Zhao Y, et al. A prospective multicenter study of systemic reactions in standardized specific immunotherapy for allergic rhinitis in China[J]. Am J Rrhinol Allergy, 2014, 28(1):e40-e44.
[1] WANG Tan, WU Ke, LI Lianqing, GONG Lili. Factors associated with systemic adverse reactions after subcutaneous immunotherapy injections and treatment options [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 71-74.
[2] LU Hangui, LIN Xinsheng, YAO Danmian, WEI Yongxin, LI Chuangwei. Expression of IL-35 in allergic rhinitis and its effect on the immunoregulation of T cells [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 66-70.
[3] PU Hongbo, DU Xiaodong. Allergen test results in 2 000 patients with allergic rhinitis in Wuxi District [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 105-107.
[4] CHEN Ming, YU Xuefei. Opinions on the treatment of chronic rhinosinusitis with allergic rhinitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 18-22.
[5] WU Xiangping. Influence of patient management on the clinical effect of sublingual dermatophagoides farinae drops in patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 68-72.
[6] LIU Jie, QU Hui, LU Daowen, XIN Huaxiu, GUO Yanli. Spring pollinosis in Qingdao west district [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 70-72.
[7] LI Song, WANG Zonggui, YANG Jingpu, ZHANG Zhuping. Progress of transnasal endoscopic vidian neurectomy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 72-76.
[8] ZHI Lili, SONG Daoliang. Expressions of eosinophils and IL5 in antrochoanal polyps and nasal polyps. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 43-46.
[9] ZHANG Xiaoli, YU Hong, HAN Dongmei, YANG Ruimin, QI Wei. Lacrimal duct laser combined with drainage tube implantation for the treatment of lacrimal duct obstruction. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 84-86.
[10] WAN Wenjin, WANG Wen, CHENG Lei. A meta-analysis of subcutaneous immunotherapy and sublingual immunotherapy in the treatment of dust mite-allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 103-108.
[11] ZHU Xinhua. Clinical applicationof rush immunotherapy for allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 13-17.
[12] SHI Li, ZHAO Li, ZHANG Hongping. Long-term anti-inflammatory treatment of allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 9-12.
[13] LIU Jing. Treatment of allergic rhinitis using syndrome differentiation based on the concept of “holism” in TCM. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 28-30.
[14] CHENG Lei, QIAN Junjun, TIAN Huiqin. Research progresses on allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 1-3.
[15] XU Yu， TAO Zezhang. Pharmacotherapeutic strategies for allergic rhinitis:Ithe importance of individualization and normalization. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 4-8.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd